[Translation] A multicenter, randomized, double-blind, placebo-controlled, parallel-design Phase II clinical study to evaluate the efficacy and safety of HRS9950 tablets in patients with chronic hepatitis B who have achieved virological suppression after treatment with nucleoside (acid) analogs (NAs).
评价 HRS9950 片在经 NAs 治疗达病毒学抑制的慢性乙型肝炎患者中的有效性和安全性
[Translation] To evaluate the efficacy and safety of HRS9950 tablets in patients with chronic hepatitis B who have achieved virological suppression after NA treatment.